Novartis will discontinue studies of an experimental lung-cancer cancer drug because of disappointing trial results.
Continue reading Novartis Halts Lung Cancer Drug Study
Novartis Halts Lung Can…
AIG (AIG) said that CEO Robert Benmosche has cancer and is undergoing aggressive chemotherapy.
“The good news is that I feel fine, and I continue to work according to my normal schedule,” Benmosche said in a statement. “I remain absolutely committed to my job, to AIG, and to all of our stakeholders.”
Benmosche said that he would have “a better idea” of his long-term prognosis over…
Continue reading AIG Says CEO Benmosche Has Cancer
AIG Says CEO Benmosche Has Cancer originally appeared on DailyFinance on Tue, 26 Oct 2010 06:26:00.
Filed Under: Company News, People, American International Group, Insurance
Traditional chemotherapy for cancer patients is as dreaded as the disease itself. But Delcath’s “Chemosaturation System,” which is doing well so far in tests, promises to deliver treatments far more precisely, thus limiting sid…
Dendreon’s Provenge, which targets prostate cancer, catapulted that company’s stock to record highs recently. Prima Biomed’s CVac works similarly, but it has the potential to target multiple forms of cancer, giving the company …
A proposed Hodgkin’s lymphoma treatment returned positive test results in a clinical trial, according to drugmaker Seattle Genetics Inc., which seeks to file the drug for approval with the U.S. Food and Drug Administration next…